Delays in court approval of settlements in their pelvic mesh class actions against US giants Johnson & Johnson and Boston Scientific have been blamed for Shine Lawyers’ 89.39 per cent decline in net profits for 2023.
Subscribe for instant access to all Lawyerly content.